MENU
FULC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fulcrum Therapeutics (FULC) Ownership - Who owns Fulcrum Therapeutics?
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
76
Web
https://www.fulcrumtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
337.37M
P/E Ratio
N/A
Total Cash
226.6M
Projected Growth
N/A
Total Debt
8.11M
Revenue
80M
Risk (Beta)
1.83
Dividend Yield
N/A
Total Cash/Share
4.20
Total Debt/Equity
N/A
Revenue/Share
1.29 USD as % of share price
Fundamentals
FULC
Capitalization
337M
P/E Ratio
N/A
Risk (Beta)
1.83
Dividend Yield
N/A
Total Cash
227M
Total Cash/Share
4.20
Total Debt
8.11M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.29%
Revenue
80M
ROE
N/A
Book Value
228M
P/B Ratio
1.48
Cash Flow
N/A
Earnings
-0.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
28.71
Current Revenue Per Employee
898876.40
Dividends Per Share - Security
N/A
EBITDA
-8.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-0.21
Shares Held By Institutions
285M
Shares Outstanding - Current
54M
Total Liabilities
14.2M
Total Volume MTD
N/A
Value
1
Gain YTD
32.979
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
76
Web
https://www.fulcrumtx.com